HONG KONG, April 1, 2015 /PRNewswire/ — Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" or the "Company"; stock …
Read MoreTag: PHA
Analysts Predict a Big Year for Healthcare in 2015
–Find out what lies ahead as Frost & Sullivan’s healthcare futurists offer their bold predictions for the entire …
Read MoreDaiichi Sankyo Launches New Formulation of LIXIANA(R) 60 mg Tablets (edoxaban) in Japan
TOKYO, Dec. 8, 2014 /PRNewswire/ — Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it …
Read MoreFrost & Sullivan Honors Codonics for Enhancing Patient Safety and Accuracy of Medication Management with the Safe Label System (SLS)
– SLS’s elegant design and integration of hardware and software elements provide a best practice approach to safe …
Read MoreFirst Tele-health Programme for Heart Failure Patients in Singapore Enables Patients to Better Manage their Health and Reduce Hospitalisation
SINGAPORE, Sept. 4, 2014 /PRNewswire/ — The Eastern Health Alliance (EH Alliance) and Changi General Hospital (CGH) …
Read MoreTakeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS
— No overall statistically significant increased risk of bladder cancer in patients ever exposed to pioglitazone in a …
Read MoreCAIDE Looks into the Future: New App from Merz Pharmaceuticals Assesses the Risk of Getting Dementia Within the Next 20 Years
FRANKFURT AM MAIN, Germany, Aug. 29, 2014 /PRNewswire/ — The CAIDE Dementia Risk App from Merz Pharmaceuticals …
Read MoreCPhI & P-MEC China 2014 Event Achieved its Grand Closing
Leading Global Industry Trends, Lighting up the China Pharmaceutical Dream
 |
SHANGHAI, Aug. 26, 2014 /PRNewswire/ — CPhI, …
Read More